PRODUCTS LIABILITY LITIGATION
Monsanto’s Roundup® contains Glyphosate and a surfactant that have been proven in multiple trials to cause non-Hodgkin Lymphoma in humans.
Roundup® contains a surfactant that opens the pores of the weed it is sprayed on in order to cause the weed to absorb the Glyphosate more readily. Glyphosate is a non-selective herbicide, meaning it will kill most plants. It prevents the plants from making certain proteins that are needed for plant growth. Roundup® also contains other “inert” ingredients that increase the potency of the mixture.
The surfactant also works on the human body, opening the pores on human skin so that it may absorb Glyphosate that is spilled or sprayed onto the skin of a worker. The combination of the Glyphosate, the surfactant, and the other ingredients has been found to cause non-Hodgkin Lymphoma. Monsanto’s warnings on this product fail to warn users of the cancer risk.
Juries in recent cases have awarded millions of dollars in damages to workers suffering from non-Hodgkin Lymphoma. One jury awarded $289 million to a school grounds keeper who developed non-Hodgkin Lymphoma as a result of routine occupational use of Roundup®. Another jury awarded $80 million with $75 million in punitive damages, for Monsanto’s willful and wanton conduct.
Plaintiffs in these cases and others have alleged that Monsanto failed to provide adequate warnings or other clinically relevant information and data regarding the appropriate use of its Roundup® products and the risks associated with the use of or exposure to Roundup® and the Glyphosate contained in it. They also allege that Monsanto knew or should have known of the risk and failed to properly test its product to determine the impact of the product on humans.
If you have been diagnosed with Non-Hodgkin Lymphoma and routinely used Roundup® in the past, contact us. We can help.